Clinical trial
Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
NCT04702451 is registered in ClinicalTrials.gov with Volta Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
- Lead sponsor
- Volta Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 12, 2021
- Completion date
- December 27, 2023
- Enrollment
- 377 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.